DK1033990T3 - 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud - Google Patents

21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud

Info

Publication number
DK1033990T3
DK1033990T3 DK98956833T DK98956833T DK1033990T3 DK 1033990 T3 DK1033990 T3 DK 1033990T3 DK 98956833 T DK98956833 T DK 98956833T DK 98956833 T DK98956833 T DK 98956833T DK 1033990 T3 DK1033990 T3 DK 1033990T3
Authority
DK
Denmark
Prior art keywords
oxidoprogesterone
hydroxy
drug
treatment
glucocorticoid excess
Prior art date
Application number
DK98956833T
Other languages
Danish (da)
English (en)
Inventor
Gerardo Burton
Carlos Pedro Lantos
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1033990T3 publication Critical patent/DK1033990T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98956833T 1997-09-23 1998-09-22 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud DK1033990T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97116526A EP0903146A1 (de) 1997-09-23 1997-09-23 21-Hydroy-6,19-oxidoprogesterone (21-0H-60P) als ANitoglucocortikoid
PCT/EP1998/006021 WO1999015181A1 (en) 1997-09-23 1998-09-22 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) and its use as medicament for treating excess of glucocorticoids

Publications (1)

Publication Number Publication Date
DK1033990T3 true DK1033990T3 (da) 2002-07-08

Family

ID=8227390

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98956833T DK1033990T3 (da) 1997-09-23 1998-09-22 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud

Country Status (13)

Country Link
US (1) US6303591B1 (de)
EP (2) EP0903146A1 (de)
AR (1) AR023008A1 (de)
AT (1) ATE215373T1 (de)
AU (1) AU738522B2 (de)
CA (1) CA2303817C (de)
DE (1) DE69804659T2 (de)
DK (1) DK1033990T3 (de)
ES (1) ES2172937T3 (de)
IL (1) IL135232A (de)
PT (1) PT1033990E (de)
WO (1) WO1999015181A1 (de)
ZA (1) ZA988674B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01011018A (es) 1999-04-30 2002-05-06 Pfizer Prod Inc Moduladores del receptor glucocorticoide.
US7713989B2 (en) 2000-04-27 2010-05-11 Dow Robert L Glucocorticoid receptor modulators
ES2271090T3 (es) * 2000-09-18 2007-04-16 Applied Research Systems Ars Holding N.V. Metodo para la preparacion de 21-hidroxi-6,19-oxidoprogesterona (21oh-60p).
PT1330468E (pt) * 2000-09-18 2007-09-13 Serono Lab Análogos de enxofre de 21-hidroxi-6, 19-oxidoprogesterona ( 21oh-60p) para tratar excesso de glucocorticóides.
EP1201660B1 (de) 2000-10-30 2005-08-31 Pfizer Products Inc. Glucocorticoid Rezeptor Modulatoren
US8097606B2 (en) * 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
EP1886695A1 (de) * 2006-06-27 2008-02-13 Speedel Experimenta AG Pharmazeutische Kombinationen mit einem Aldosteron Synthasehemmer und Glucocorticoid Rezeptorantagonisten oder Cortisol Synthasehemmer oder Corticotropin Releasing Faktor Antagonisten
DK2054049T3 (en) 2006-08-24 2016-08-01 Univ Tennessee Res Found SUBSTITUTED ACYLANILIDES AND PROCEDURES FOR USING THEREOF
EP2576582B1 (de) 2010-05-26 2019-09-18 Corcept Therapeutics, Inc. Behandlung von muskeldystrophie
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
CN104754939A (zh) 2012-07-13 2015-07-01 Gtx公司 用选择性雄激素受体调节剂(sarm)治疗雄激素受体(ar)阳性乳癌的方法
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
EP3265127B1 (de) 2015-03-02 2024-02-21 Corcept Therapeutics, Inc. Mifepriston und octreotid zur verwendung bei der behandlung des cushing-syndroms bei einem patienten mit einem adrenocorticotropen hormon (acth) sezernierenden pankreatischen neuroendokrinen tumor
AU2016243625B2 (en) 2015-03-30 2020-09-10 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
CA2994422A1 (en) 2015-08-13 2017-02-16 Corcept Therapeutics, Inc. Method for differentially diagnosing acth-dependent cushing's syndrome
ES2861524T3 (es) 2016-01-19 2021-10-06 Corcept Therapeutics Inc Diagnóstico diferencial del Síndrome de Cushing Ectópico
CA3065555A1 (en) 2017-06-20 2018-12-27 Corcept Therapeutics, Inc. Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
JP2022515528A (ja) * 2018-12-28 2022-02-18 パンダ コンサルティング エルエルシー 短時間作用型選択的糖質コルチコイド受容体モジュレーター

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
CN1187053C (zh) * 1997-10-06 2005-02-02 利兰·斯坦福青年大学托管委员会 糖皮质素受体拮抗剂用于制造治疗精神病药物的用途

Also Published As

Publication number Publication date
ATE215373T1 (de) 2002-04-15
IL135232A0 (en) 2001-05-20
AR023008A1 (es) 2002-09-04
IL135232A (en) 2005-05-17
PT1033990E (pt) 2002-07-31
AU1334199A (en) 1999-04-12
EP1033990A1 (de) 2000-09-13
EP0903146A1 (de) 1999-03-24
ES2172937T3 (es) 2002-10-01
EP1033990B1 (de) 2002-04-03
CA2303817C (en) 2008-04-01
AU738522B2 (en) 2001-09-20
ZA988674B (en) 1999-06-28
DE69804659T2 (de) 2002-10-02
CA2303817A1 (en) 1999-04-01
DE69804659D1 (de) 2002-05-08
WO1999015181A1 (en) 1999-04-01
US6303591B1 (en) 2001-10-16

Similar Documents

Publication Publication Date Title
DK1033990T3 (da) 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud
NO20002217D0 (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
DE69830369D1 (de) Wegwerfbare, zahnärztliche Auftragevorrichtung
DE69838405D1 (de) Mikrostrukturierte, kosmetisch verträgliche Zusamensetzungen
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
ID21115A (id) Isokuinolin-3-karboksamida tersubstitusi, pembuatannya serta penggunaannya sebagai obat
NO20002546D0 (no) Flerkomponent, superabsorberende gelpartikler
NO993003D0 (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
IS5425A (is) Læknislyf
NO20006138L (no) Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
DK1006110T3 (da) Derivater af acylpiperazinylpyrimidiner, fremstilling deraf og anvendelse som lægemidler
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
FI963183A (fi) Vesipitoinen dispersiokoostumus, ja sitä käyttävä koostumus
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1073416T3 (da) Anvendelse af NO som anti-inflammatorisk middel
ID22228A (id) Turunan-turunan 16-hidroksi-11-(disubstitusifenil)-estra-4,9-diena
DK0903339T3 (da) Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament
NO981846D0 (no) Beskyttelsesbrille, spesielt arbeidsbeskyttelsesbrille
NO995513L (no) N-triazolyl-2-indolkarboksamider og deres anvendelse som CCK-
FI941307A0 (fi) Tjulvalarm, som aktiveras av foeremaolets, som skall skyddas, roerelse
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
ES1038353Y (es) Jeringuilla perfeccionada.